Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ca13c4722a27ea4278793256a710e0a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16632 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-763 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_083881be61a0e7864b78c2e8e6028e5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb5ea9338b77e1aa660df525e7aaaa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d0329485c7243d538a0b9814739f0c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_824c7e3a3ab69c7758e3c3e462d2157d |
publicationDate |
2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020132946-A1 |
titleOfInvention |
Pharmaceutical compositions, kits and methods for treating tumors |
abstract |
Provided is a composition for treating tumors in a subject comprising a therapeutically effective amount of an exosome carrying inhibitory amount of CTLA4-targeting miRNA and an oncolytic virus, wherein an exo-motif is operably linked to the seed sequence of the CTLA4-targeting miRNA to enhance the packaging of the CTLA4-targeting miRNA into the exosome. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113528526-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3994269-A4 |
priorityDate |
2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |